Ready to dive deep into peptide therapy? This massive guide covers 65+ peptides with exact dosages, clinical references, and uses—from BPC-157 to Semaglutide to Epithalon. The most comprehensive resource I've seen. Bookmark this one!
Click here for a formatted version: List of Peptides and Their Evidence
IMPORTANT SAFETY WARNING
FDA Approval Status: Of the peptides listed in this document, only four have been approved by the U.S. Food and Drug Administration (FDA) for specific medical uses:
1. Sermorelin - Approved for diagnostic testing of growth hormone secretion
2. Semaglutide - Approved for type 2 diabetes management and chronic weight management
3. Tirzepatide - Approved for type 2 diabetes management and chronic weight management
4. Tesamorelin - Approved for reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
All other peptides listed in this document are NOT FDA-approved for human use and are considered experimental, research compounds, or are used off-label.
1. Adipotide (FTPP)
Description: Experimental peptide targeting blood vessels in adipose tissue for weight loss
Clinical/Research Dosages:
Description: AMP-activated protein kinase activator for metabolic regulation and endurance
Clinical/Research Dosages:
Description: Fragment of human growth hormone for fat reduction and metabolic function
Clinical/Research Dosages:
Description: Tissue-protective peptide for neuropathy and inflammatory conditions
Clinical/Research Dosages:
Description: Cardioprotective peptide for heart and vascular function
Clinical/Research Dosages:
Description: Body protection compound promoting healing and tissue repair
Clinical/Research Dosages:
Description: Bioregulator peptide supporting bronchial and respiratory system health
Clinical/Research Dosages:
Description: Combination therapy of cagrilintide and semaglutide for obesity treatment
Clinical/Research Dosages:
Description: Amylin analog for appetite regulation and weight management
Clinical/Research Dosages:
Description: Cardiac bioregulator supporting heart function and cardiovascular health
Clinical/Research Dosages:
Description: Bioregulator peptide for cartilage and musculoskeletal tissue support
Clinical/Research Dosages:
Description: Neuropeptide preparation for cognitive function and neurological conditions
Clinical/Research Dosages:
Dosage: 1-2 capsules (0.1mg each) once or twice daily before meals, OR 1-5mg injection daily for 10-30 days
Sources:
Dosage: 1-2mg (1000-2000mcg) once weekly, OR 30-60mcg/kg subcutaneous injection
Sources:
15. Cortagen - Supports brain and nervous system health
Dosage: 10 micrograms/kg body weight (approximately 1mg daily for a 100kg person) via intramuscular or subcutaneous injection for 5-10 days
Sources:
Dosage: 25-100mcg (25 nmol/kg body weight clinically tested) before bed, subcutaneous or intranasal injection
Sources:
Dosage: 5-10mg (5000-10,000mcg) daily for 10-20 days, repeated 2-3 times per year. Some protocols use 10-20mg daily.
Sources:
Dosage: 100mcg daily subcutaneous injection for 10-30 day cycles. Advanced users: 150-300mcg daily.
Sources:
Dosage: 100-300mcg per injection, 2-3 times daily on empty stomach (subcutaneous or intramuscular)
Sources:
Dosage: 1-3mg daily subcutaneous injection, OR topical application (2-10% concentration in creams), OR 120mcg oral tablets daily
Sources:
Dosage: 200-300mcg per injection, 2-3 times daily on empty stomach (subcutaneous), OR 0.03mg/kg twice daily in clinical settings
Sources:
Dosage: 500-2000mg daily oral, OR 1000-1400mg IV 2-3 times weekly, OR 250-1000mg subcutaneous injection
Sources:
Dosage: 10-25mg daily oral administration (commonly 25mg). Starting dose: 10-15mg per day.
Sources:
Description: Growth hormone secretagogue with cardioprotective properties
Dosage: 100-300 mcg, 2-3 times daily (subcutaneous injection)
Clinical References:
Description: Mitochondrial-derived peptide for lifespan and metabolic health
Dosage: Research stage - varies widely from 0.1 mg/kg to 10 mg/kg; practical protocols suggest 5-10 mg per week
Clinical References:
Description: Reproductive hormone regulator stimulating LH and FSH release
Dosage: Research varies widely - 0.3-1.0 nmol/kg IV; practical use 100-200 mcg subcutaneous
Clinical References:
Description: Anti-inflammatory tripeptide for inflammatory bowel disease and immune modulation
Dosage: 200-500 mcg daily (injectable); 250-500 mg oral capsules; 10-20 mg daily experimental
Clinical References:
Description: GLP-1 receptor agonist for type 2 diabetes and weight management
Dosage: 0.6-1.8 mg daily (diabetes); 3.0 mg daily (weight loss) - prescription medication
Clinical References:
Description: Bioregulator peptide affecting DNA structure and digestive enzyme activity
Dosage: 2 mg (20 units) daily; 10-20 drops equivalent
Clinical References:
Clinical trials have used LL-37 (Ropocamptide) at concentrations of 0.5 mg/mL and 1.6 mg/mL applied twice weekly for topical wound healing. For systemic use, typical dosages range from 100-125 mcg daily via subcutaneous injection, sometimes divided into two doses of 50-60 mcg each, with weight-based dosing at 50 mcg per kilogram of body weight per day.
Sources:
In clinical trials, Melanotan II was administered at doses starting from 0.01 mg/kg, escalating to 0.025-0.03 mg/kg subcutaneously. For tanning and sexual enhancement, typical dosing is 0.025 mg/kg daily (approximately 250-500 mcg for most adults), with protocols starting at 0.5 mg daily for the first week, then increasing to 1-2 mg daily.
Sources:
In the Phase 3 GLORY-1 trial, Mezdutide was administered at doses of 4 mg or 6 mg once weekly via subcutaneous injection, with treatment lasting 32-48 weeks and producing significant weight loss. Earlier phase trials explored higher doses up to 9-10 mg weekly with dose escalation protocols.
Sources:
Common dosing protocols for PEG-MGF (a stabilized form) involve approximately 200 mcg per day, often administered post-workout. In animal studies, MGF C-terminal peptide was administered at doses of 28.5-57 μg/kg body weight for bone healing applications.
Sources:
ModGRF 1-29 has a short half-life of approximately 30 minutes and is typically dosed at 100-200 mcg once or twice daily. Clinical studies have used CJC-1295 at doses of 30-60 mcg/kg administered subcutaneously, producing sustained increases in GH and IGF-1 levels.
Sources:
Research protocols typically use 5 mg of MOTS-c via subcutaneous injection every 5 days, or 10 mg up to 3 times weekly for more intensive protocols. Clinical dosing involves 0.5 mg (500 mcg) subcutaneously twice weekly for 4-6 weeks.
Sources:
Epithalon dosing protocols typically involve 10-day treatment courses administered no more than twice yearly, with clinical studies using intranasal delivery at 10-30 mg/day for 20-30 days or intramuscular injection at 5-10 mg/day for 10-20 days. N-Acetyl Epithalon Amidate is expected to have similar dosing to standard Epithalon but with enhanced stability and bioavailability.
Sources:
Based on Selank clinical data, typical dosing involves 250-750 mcg daily administered intranasally, with Russian clinical protocols using 0.15% solution (75 mcg per drop) three times daily for up to 14 days. For N-Acetyl Selank Amidate specifically, research protocols use 250-500 mcg per dose, 1-2 times daily via intranasal spray or subcutaneous injection.
Sources:
Description: Nootropic peptide for cognitive enhancement and neuroprotection
Dosage: 300-600mcg daily (nasal or subcutaneous)
Sources:
Description: Essential coenzyme for cellular energy production and anti-aging
Dosage: 250-750mg IV; 100-150mg sublingual daily
Sources:
Description: Liver and gastrointestinal tract bioregulator for digestive health
Note: Ovagen is a liver and GI tract bioregulator, NOT for ovarian health as originally described.
Dosage: 1-2 capsules 1-2 times daily (oral); standard research dose for peptide
Sources:
41. Oxytocin
Description: Social bonding hormone with pain modulation and anxiolytic effects
Dosage: 10-40 IU nasal spray (typically 24-32 IU daily in clinical studies)
Sources:
Description: Pancreatic bioregulator supporting pancreatic function and metabolic health
Dosage: 1-2 capsules 1-2 times daily; 20 units (2mg) daily for research
Sources:
42, PE-22-28
Description: Neurogenic peptide with antidepressant and cognitive enhancement properties
Dosage: 400-600mcg daily (intranasal); Research stage with limited human data
Sources:
43. PEG-MGF
Description: Pegylated mechano growth factor for muscle repair and recovery
Dosage: 200mcg 2-3x weekly post-training
Sources:
44. Pinealon
Description: Brain bioregulator peptide for neuroprotection and cognitive support
Dosage: 0.1-0.2mg twice daily; 4-6 drops (sublingual) 3-4x daily
Sources:
Description: Experimental anti-cancer peptide (FDA warning issued - not approved for use)
Dosage: Highly experimental - NO established safe human dosing
FDA WARNING: The FDA issued a warning against PNC-27 use in 2017 due to bacterial contamination and lack of approval.
Sources:
Description: Prostate bioregulator for benign prostatic hyperplasia and prostate health
Dosage: 10-20mg daily (capsules or drops); 2 capsules daily for 30 days
Sources:
Dosage Information:
Dosage Information:
Dosage Information:
Dosage Information:
Dosage Information:
Dosage Information:
Dosage Information:
Dosage Information:
Dosage Information:
Description: Thymosin beta-4 fragment promoting tissue repair and injury recovery
Dosage: Loading phase of 2-2.5 mg twice per week for 4-6 weeks (total 4-5 mg per week), followed by maintenance phase of 2 mg once every 1-2 weeks.
Sources:
Description: Growth hormone releasing hormone for visceral fat reduction
Dosage: 2 mg daily administered subcutaneously for visceral fat reduction in HIV patients. FDA-approved for reducing excess abdominal fat in HIV-infected patients with lipodystrophy.
Sources:
Description: Bioregulator peptide for testosterone regulation and male vitality
Dosage: 20 mg per injection via subcutaneous administration, with treatment cycles spanning several weeks. One capsule each morning daily for thirty days, repeat every three to six months.
Sources:
Description: Thymus bioregulator for immune system support and regeneration
Dosage: Typical dosage is 20 mg per injection via subcutaneous administration, with treatment cycles lasting several weeks. Daily injections ranging from 5-20 mg for 5-10 day courses.
Sources:
Description: Thyroid stimulating hormone releasing factor for thyroid function testing
Dosage: Standard test dose of 400 μg administered intravenously for evaluating TSH secretion, as doses of 800 μg produced no greater response. Each vial contains 500 mcg protirelin for intravenous administration.
Sources:
Description: Dual GIP/GLP-1 receptor agonist for type 2 diabetes and obesity
Dosage: Starting dose of 2.5 mg weekly, may increase to 15 mg weekly for weight loss. At 5 mg per week dosing, showed 2.11% reduction in HbA1c, and at 15 mg per week showed 2.34% reduction.
Sources:
Description: GnRH agonist for prostate cancer treatment and reproductive regulation
Dosage: 3.75 mg IM every 4 weeks, 11.25 mg IM every 12 weeks, or 22.5 mg IM every 24 weeks for prostate cancer. For IVF treatment, minimal daily dose of 15 microgram daily has been determined.
Sources:
Description: Vascular bioregulator supporting blood vessel health and circulation
Dosage: Take 1-2 capsules one to two times daily, 30 minutes before meals for 1 month, repeat every 4-6 months. Daily dose of 2-5 ml sublingual contains 0.1 mg of peptide complex AC-2 for 10 days.
Sources:
Description: Bladder and urinary tract bioregulator peptide
Dosage: In research settings, typically dosed at 10-20 mg per week administered subcutaneously in 2-3 injections per week for 2 to 6 weeks. One capsule twice daily (morning and evening) during meals for at least 20 days, repeat after 4-6 months.
Sources:
Description: Immune system bioregulator affecting thymus function and cellular immunity
Dosage: For research, typically administered subcutaneously at 5 mg per day over a 12-day cycle, repeated every four to six months. Clinical dosing is individualized but commonly follows a 10-day cycle every 3-6 months.
Sources:
Description: Neuropeptide with vasodilatory and anti-inflammatory effects
Dosage: Graded doses of 0.6, 1.3, and 3.3 pmol/kg/min were intravenously infused over 30 minute periods in clinical studies. For nasal spray administration, 1 spray (50 mcg) four times daily alternating nostrils for the first month, may increase to 2 sprays (100 mcg) four times daily for the second month.
Sources:
1. Legal and Safety Risks:
• Non-FDA-approved peptides have not undergone rigorous safety and efficacy testing required by regulatory authorities
• Manufacturing standards, purity, and dosing accuracy may vary significantly between sources
• Long-term effects and potential adverse reactions are often unknown or poorly documented
• Use of non-approved compounds may carry legal implications depending on your jurisdiction
2. Source Verification:
• Never purchase peptides from unverified or questionable sources
• Contamination, mislabeling, incorrect concentrations, and counterfeit products are serious concerns in the unregulated peptide market
• Even compounds labeled as “research use only” or “not for human consumption” may be marketed for human use inappropriately
• Third-party testing and certificates of analysis (COAs) should be verified independently when possible
3. Medical Supervision:
• Always consult with a qualified healthcare provider before using any peptide
• Self-administration of experimental compounds without medical supervision can be dangerous
• Pre-existing health conditions, medications, and individual factors can significantly affect safety and outcomes
• Regular monitoring and lab work may be necessary to prevent adverse effects
Click here for a formatted version: List of Peptides and Their Evidence
IMPORTANT SAFETY WARNING
FDA Approval Status: Of the peptides listed in this document, only four have been approved by the U.S. Food and Drug Administration (FDA) for specific medical uses:
1. Sermorelin - Approved for diagnostic testing of growth hormone secretion
2. Semaglutide - Approved for type 2 diabetes management and chronic weight management
3. Tirzepatide - Approved for type 2 diabetes management and chronic weight management
4. Tesamorelin - Approved for reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
All other peptides listed in this document are NOT FDA-approved for human use and are considered experimental, research compounds, or are used off-label.
1. Adipotide (FTPP)
Description: Experimental peptide targeting blood vessels in adipose tissue for weight loss
Clinical/Research Dosages:
- Primate studies: 0.43 mg/kg daily for 4 weeks showed weight loss without major side effects
- Phase I clinical trials: Daily subcutaneous injections for 28 days (dose escalation study with 5 dose levels)
- Research note: No established safe human dosing - highly experimental
- Science Translational Medicine Study - PMC
- Arrowhead Pharmaceuticals Clinical Trial Announcement
- Adipotide Dosage Calculator - Peptides.org
- PEP DOSE Adipotide Research Guide
Description: AMP-activated protein kinase activator for metabolic regulation and endurance
Clinical/Research Dosages:
- Human clinical trials: 42 mg/kg IV over 7 hours (translates to ~0.1 mg/kg/min)
- Research studies: 150-500 mg/kg in animal studies
- Alternative dosing: 10-20 mg/kg/hr in some human studies
- Long-term studies: 150 mg/kg/day for 5 weeks in obesity research
- AICAR Dosage Calculator - Peptides.org
- Diabetes Journal - Long-term AICAR Administration
- Chemical Book - AICAR Mechanism and Dosage
- AICAR Systematic Review - PMC
Description: Fragment of human growth hormone for fat reduction and metabolic function
Clinical/Research Dosages:
- Human clinical trials: 250-500 mcg daily (0.25-1 mg daily for 24 weeks showed good safety)
- Optimal range: 300-500 mcg daily via subcutaneous injection
- IV studies: 25-400 µg/kg bodyweight
- Oral studies: 9-54 mg doses
- Journal of Endocrinology - Safety and Tolerability Study
- Alpha Rejuvenation AOD9604 Dosage Guide
- Journal of Endocrinology - Safety and Metabolism Study
- PubMed - Metabolic Studies
Description: Tissue-protective peptide for neuropathy and inflammatory conditions
Clinical/Research Dosages:
- Standard dosing: 2-4 mg daily subcutaneous injection
- Clinical trials: 2 mg IV three times weekly for 4 weeks
- Diabetes study: 4 mg daily subcutaneous for 28 days
- Research range: 2-8 mg daily
- Molecular Medicine - ARA-290 Type 2 Diabetes Study
- PMC - Sarcoidosis Neuropathy Study
- PEP DOSE ARA-290 Research Protocol
- PMC - Corneal Nerve Fiber Study
Description: Cardioprotective peptide for heart and vascular function
Clinical/Research Dosages:
- Animal studies: 0.25 mg/kg IP daily for cardiac protection
- Extended studies: 0.5 mg/kg daily for 7-day treatments
- Vascular studies: 13.3 μg/kg IV single dose (equivalent to 26.6 μg/kg serelaxin)
- Research note: Experimental, no established human dosing
- Journal of the American Heart Association - B7-33 Cardiac Study
- PubMed - B7-33 Myocardial Infarction Study
- PubMed - B7-33 Vascular Function Study
- ScienceDirect - B7-33 Cardioprotective Effects
Description: Body protection compound promoting healing and tissue repair
Clinical/Research Dosages:
- Standard research: 200-500 mcg daily (most common 200-500 mcg range)
- Human equivalent: 1.6 μg/kg (converted from 10 μg/kg rat studies)
- Clinical trial: 200 μg/person/day for 7 days (3.33 μg/kg/day)
- Intravesical: 10 mg injected into bladder wall for interstitial cystitis
- Safety note: Well tolerated in preclinical studies, limited human data
- PMC - BPC-157 Growth Hormone Receptor Study
- Examine.com - BPC-157 Research Breakdown
- ScienceDirect - BPC-157 Preclinical Safety
- Peptides.org - BPC-157 Dosage Calculator
Description: Bioregulator peptide supporting bronchial and respiratory system health
Clinical/Research Dosages:
- Standard dosing: 1-2 capsules, 1-2 times per day (bioregulator format)
- Duration: 20-30 days, repeat after 4-6 months
- Research format: 20mg vials for reconstitution
- Administration: Typically 10-20 drops or equivalent for bioregulator preparations
- Peptide Sciences - Bronchogen Product Information
- CosmicNootropic - Bronchogen Dosage Guidelines
- Core Peptides - Bronchogen Research Study
- Jay Campbell - Bronchogen Clinical Guide
Description: Combination therapy of cagrilintide and semaglutide for obesity treatment
Clinical/Research Dosages:
- Phase 3 trials: 2.4 mg cagrilintide + 2.4 mg semaglutide weekly
- REDEFINE 1: 68-week study in obesity without diabetes
- REDEFINE 2: 68-week study in type 2 diabetes with obesity
- Phase 2: 32-week study at 2.4 mg each component
- Status: Investigational, clinical trials ongoing
- New England Journal of Medicine - REDEFINE 1 Trial
- New England Journal of Medicine - REDEFINE 2 Trial
- PubMed - Phase 2 CagriSema Study
- American Diabetes Association - CagriSema Results
Description: Amylin analog for appetite regulation and weight management
Clinical/Research Dosages:
- Phase 2 trials: 0.3-4.5 mg weekly subcutaneous (dose-finding study)
- Phase 3 trials: 2.4 mg weekly (REDEFINE program)
- Optimal dose: 2.4 mg once weekly subcutaneous
- Combination therapy: 2.4 mg cagrilintide + 2.4 mg semaglutide weekly (CagriSema)
- Treatment duration: 26-68 weeks in clinical trials
- New England Journal of Medicine - Cagrilintide Clinical Trial
- PubMed - Phase 2 Dose-Finding Study
- ScienceDirect - Phase 2 Combination Trial
- Peptides.org - Cagrilintide Dosage Calculator
Description: Cardiac bioregulator supporting heart function and cardiovascular health
Clinical/Research Dosages:
- Standard bioregulator protocol: 1-2 capsules, 1-2 times daily
- Treatment course: 20-30 days, repeat every 4-6 months
- Research format: 20mg vials for reconstitution
- Administration: 10-20 drops or equivalent for bioregulator preparations
- Severe cases: May increase frequency to every 2 months
- Peptide Sciences - Cardiogen Product Information
- Jay Campbell - Cardiogen Clinical Guide
- Core Peptides - Cardiogen Research Study
- Swolverine - Cardiogen Research Applications
Description: Bioregulator peptide for cartilage and musculoskeletal tissue support
Clinical/Research Dosages:
- Intensive course: 2 capsules daily for 30 days (60 capsules total)
- Maintenance: 2 capsules daily for 10 days every 3 months (20 capsules)
- Severe cases: 20 capsules every 2 months or monthly
- Administration: 5-10 minutes before meals in morning
- Sublingual drops: 10-20 drops or equivalent
- Peptide Sciences - Cartalax Bioregulator
- Antiaging Systems - Cartalax Dosing Protocol
- CosmicNootropic - Cartalax Bioregulator
- iPept - Cartalax Dosage Guidelines
Description: Neuropeptide preparation for cognitive function and neurological conditions
Clinical/Research Dosages:
- Standard clinical dose: 10-30 mL daily IV for 10-21 days
- Acute stroke: 30 mL daily IV for 10-21 days
- Dementia: 5-30 mL daily IV
- Traumatic brain injury: 10-60 mL daily IV
- Administration: IV infusion over 30-45 minutes (preferred) or slow IV injection
- IM injection: Up to 5 mL undiluted
- Direct IV: Up to 10 mL over 3 minutes
- Cerebrolysin Official Treatment Handbook
- MIMS Philippines - Cerebrolysin Prescribing Information
- Stroke Journal - CARS Clinical Trial
- Vinmec - Cerebrolysin Clinical Usage
Dosage: 1-2 capsules (0.1mg each) once or twice daily before meals, OR 1-5mg injection daily for 10-30 days
Sources:
- Chonluten Peptide: Uses, Benefits, Side Effects and Dosage
- https://www.peptidesciences.com/chonluten-20mg-bioregulator
- Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line - PMC
- Chonluten Peptide Benefits: Breathe Deeper, Train Harder
- Chonluten (20mg Vial) Dosage Protocol
Dosage: 1-2mg (1000-2000mcg) once weekly, OR 30-60mcg/kg subcutaneous injection
Sources:
- CJC-1295 - Wikipedia
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults - PubMed
- CJC-1295 DAC vs No DAC | Livv Natural
- CJC 1295 Peptide Guide | Yunique Medical
- CJC‑1295 For Beginners: How It Works, Benefits, Dosage, and Stacks
- CJC-1295 With DAC vs. Without DAC: Which Growth Hormone Peptide Is Bet
15. Cortagen - Supports brain and nervous system health
Dosage: 10 micrograms/kg body weight (approximately 1mg daily for a 100kg person) via intramuscular or subcutaneous injection for 5-10 days
Sources:
- https://www.peptidesciences.com/cortagen-20mg-bioregulator
- Cortagen Peptide: Uses, Benefits, Side Effects and Dosage
- Cortagen
- Account Suspended
- Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray - PubMed
- CORTAGEN - Everything you need to know | World Of Peptides
Dosage: 25-100mcg (25 nmol/kg body weight clinically tested) before bed, subcutaneous or intranasal injection
Sources:
- Delta-sleep-inducing peptide - Wikipedia
- Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study - PubMed
- https://www.mdpi.com/1420-3049/26/17/5173
- https://optimalcircadianhealth.com/delta-sleep-inducing-peptide-a-comprehensive-guide/
- DSIP Peptide: The Sleep-Optimizing Molecule for Deep Rest and Recovery
- DSIP (Delta Sleep-Inducing Peptide): Benefits, Dosage, and Risks Expla
- https://www.peptidesciences.com/dsip-5mg
- https://www.sciencedirect.com/topics/neuroscience/delta-sleep-inducing-peptide
Dosage: 5-10mg (5000-10,000mcg) daily for 10-20 days, repeated 2-3 times per year. Some protocols use 10-20mg daily.
Sources:
- Epitalon - Wikipedia
- Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells - PubMed
- Epitalon For Beginners: Benefits, Dosage, Stacks, and Anti-Aging Insig
- Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties - PMC
- Epithalon Peptide: Anti-Aging, Longevity, and Telomere Support
- Epithalon Peptide and Telomere Science: A New Frontier in Anti-Aging
- Epitalon Peptide Guide: Benefits, Uses, Dosage
- Epithalon Dosage Calculator and Chart | A-Z Guide
- Epithalon Peptide
Dosage: 100mcg daily subcutaneous injection for 10-30 day cycles. Advanced users: 150-300mcg daily.
Sources:
- INHIBITION OF MYOSTATIN WITH EMPHASIS ON FOLLISTATIN AS A THERAPY FOR MUSCLE DISEASE - PMC
- Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors - PMC
- Follistatin-344 Myostatin Inhibitor, Dosage, Half Life and Results
- Follistatin for Bodybuilding: Dosage, Supplements and FAQ
- Follistatin 344 Dosage Timing: Maximize Muscle Growth & Recovery - BDPT
- https://journals.physiology.org/doi/full/10.1152/ajpendo.00193.2009
- Follistatin 344 Peptide: Benefits, Dosage & Side Effects
- Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates - PMC
- 4 Benefits of Follistatin + Side Effects - SelfHacked
- Bodybuilding Peptides: Follistatin 344 and 315 | XCellr8 Health Scottsdale
Dosage: 100-300mcg per injection, 2-3 times daily on empty stomach (subcutaneous or intramuscular)
Sources:
- Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects - PMC
- GHRP-6 - Wikipedia
- GHRP-6 Guide: Benefits, Dosage, Side Effects, and Best Stacks
- Growth hormone releasing peptide-6 (GHRP-6) and other related secretagogue synthetic peptides: A mine of medical potentialities for unmet medical needs
- https://www.sciencedirect.com/science/article/abs/pii/S0928098712003880
- Frontiers | Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms
- GHRP-6 vs GHRP-2: Best Peptide for Muscle Growth & Recovery
Dosage: 1-3mg daily subcutaneous injection, OR topical application (2-10% concentration in creams), OR 120mcg oral tablets daily
Sources:
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data - PMC
- Copper peptide GHK-Cu - Wikipedia
- The potential of GHK as an anti-aging peptide - PMC
- GHK-Cu Peptide | The benefits, side effects, and more [2025]
- GHK-Cu Peptide Dosage | How to Use Copper Peptides, Injections
- Copper Peptide: The Ultimate Guide to GHK-Cu for Anti-Aging and Skin Repair
- https://primeivhydration.com/blog/ghk-cu-injection/
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration - PMC
Dosage: 200-300mcg per injection, 2-3 times daily on empty stomach (subcutaneous), OR 0.03mg/kg twice daily in clinical settings
Sources:
- Ipamorelin, the first selective growth hormone secretagogue - PubMed
- Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males - PMC
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers - PubMed
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats - PubMed
- Ipamorelin Benefits & Side Effects – The Truth You Need to Know
- Ipamorelin Dosage Guide: Optimal Protocols for Recovery and Muscle Growth
- Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers - Pharmaceutical Research
- https://onlinelibrary.wiley.com/doi/full/10.1002/rco2.9
- Ipamorelin - Wikipedia
Dosage: 500-2000mg daily oral, OR 1000-1400mg IV 2-3 times weekly, OR 250-1000mg subcutaneous injection
Sources:
- Glutathione: Uses, Dosage, Side Effects
- Glutathione Uses, Benefits & Dosage
- GLUTATHIONE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews
- L-Glutathione Dosage Calculator and Chart | A-Z Guide
- Glutathione Injection Dosage Per Week: A Guide to Antioxidant Therapy - The Peptide Report
- Glutathione: Uses and Risks
- 6 health benefits of glutathione
- Glutathione and its antiaging and antimelanogenic effects - PMC
- Glutathione Benefits for Your Health and Body
- Health Benefits of Glutathione
Dosage: 10-25mg daily oral administration (commonly 25mg). Starting dose: 10-15mg per day.
Sources:
- MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism - PubMed
- Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats - PMC
- What you need to know about MK-677 (Ibutamoren)
- Ibutamoren - Wikipedia
- Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults - PubMed
- MK-677: Explanation, Benefits, Side Effects
- https://academic.oup.com/jcem/article/83/2/320/2865101
- MK 677: Your Ultimate Ibutamoren Resource
- MK-677 For Beginners: What You Need To Know About Growth, Recovery, an
- Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children - PubMed
Description: Growth hormone secretagogue with cardioprotective properties
Dosage: 100-300 mcg, 2-3 times daily (subcutaneous injection)
Clinical References:
- Clinical studies show a maximal effective dose of 2 mcg/kg IV: Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects - PubMed
- Dose-response study showing ED50 of 0.48-0.64 mcg/kg: Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study - PubMed
- Clinical protocol: 0.2-0.3 mg daily, divided into 2-3 doses of 0.1 mg each: Hexarelin Peptide: Benefits, Protocol, and How It Boosts Growth Hormon
- Cardioprotective studies using 2 mcg/kg IV: The cardiovascular action of hexarelin - PMC
- Practical dosing guide: Hexarelin For Beginners: Dosage, Benefits, and Peptide Stacking Guide
Description: Mitochondrial-derived peptide for lifespan and metabolic health
Dosage: Research stage - varies widely from 0.1 mg/kg to 10 mg/kg; practical protocols suggest 5-10 mg per week
Clinical References:
- Animal studies using HNG treatment twice weekly in middle-aged mice: The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan - PMC
- Human dosing: 2-10 mg per day subcutaneous or IV administration: Humanin
- Practical protocol: 5-10 mg per week, divided into 2-3 injections: Humanin For Beginners: Benefits, Mechanism, Dosage, and Side Effects
- User experience: 1 mg twice daily for 15 days: Humanin Peptide: Benefits, Dosage and Side Effects
- Neuroprotective studies in mice and cognitive aging research: Humanin Prevents Age-Related Cognitive Decline in Mice and is Associated with Improved Cognitive Age in Humans - Scientific Reports
Description: Reproductive hormone regulator stimulating LH and FSH release
Dosage: Research varies widely - 0.3-1.0 nmol/kg IV; practical use 100-200 mcg subcutaneous
Clinical References:
- Human male studies: doses as low as 0.3-1.0 nmol/kg stimulate LH and FSH: https://academic.oup.com/jcem/article/96/8/E1228/2833644
- Sexual dimorphism study showing different responses in men vs women: The Effects of Kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans - PMC
- Optimal response at 1 mcg/kg body weight; typical dose 100-200 mcg subcutaneous: Kisspeptin-10 Dosage Calculator and Chart | A-Z Guide
- Clinical use for TRT support: 0.1-0.2 mL per injection, 2-3 times per week: Boost your sex drive with the peptide Kisspeptin? There’s more to it than that - Houston Men's Health Clinic
- FDA briefing document: https://www.fda.gov/media/182089/download
Description: Anti-inflammatory tripeptide for inflammatory bowel disease and immune modulation
Dosage: 200-500 mcg daily (injectable); 250-500 mg oral capsules; 10-20 mg daily experimental
Clinical References:
- Mouse studies: 16 mcg/kg per day for colitis treatment: Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis - PMC
- Anti-inflammatory studies in murine IBD models: Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease - PubMed
- Practical dosing: two 250 mg capsules daily, up to 2000 mg/day depending on condition: KPV Peptide Benefits, Side Effects & Dosage
- Experimental protocols: 10-20 mg daily oral administration: KPV Peptide: Anti-Inflammatory Benefits, Mechanism, and Research Guide
- Bronchial epithelial cell studies showing dose-dependent inhibition: Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists - PMC
Description: GLP-1 receptor agonist for type 2 diabetes and weight management
Dosage: 0.6-1.8 mg daily (diabetes); 3.0 mg daily (weight loss) - prescription medication
Clinical References:
- FDA-approved dosing for diabetes and weight management: Liraglutide - StatPearls - NCBI Bookshelf
- Landmark trial: 3.0 mg daily for weight management in 3,731 patients: https://www.nejm.org/doi/full/10.1056/NEJMoa1411892
- Official prescribing information and safety data: https://www.drugs.com/liraglutide.html
- Clinical review of efficacy and safety in weight management: Liraglutide for weight management: a critical review of the evidence - PMC
- Mayo Clinic dosing guide: Liraglutide (subcutaneous route) - Side effects & dosage
Description: Bioregulator peptide affecting DNA structure and digestive enzyme activity
Dosage: 2 mg (20 units) daily; 10-20 drops equivalent
Clinical References:
- Enzyme activity study in rats of different ages: [Effect of peptide Livagen on activity of digestive enzymes in gastrointestinal tract and non-digestive organs in rats of different ages] - PubMed
- Bioregulatory peptide with effects on DNA structure and gene expression: https://www.peptidesciences.com/livagen-20mg
- Recommended intake: 20 units per day (2 mg): Livagen Peptide | Price 20mg/2ml | Buy Online
- Anti-aging protocol: 2 mg daily: Livagen Peptide: Exploring Its Mechanism, Benefits, Effects, Dosage, and More
- Nanomolar concentrations showing biological activity in hepatocyte studies: Livagen peptide
Clinical trials have used LL-37 (Ropocamptide) at concentrations of 0.5 mg/mL and 1.6 mg/mL applied twice weekly for topical wound healing. For systemic use, typical dosages range from 100-125 mcg daily via subcutaneous injection, sometimes divided into two doses of 50-60 mcg each, with weight-based dosing at 50 mcg per kilogram of body weight per day.
Sources:
- Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial - PubMed
- LL-37 Dosage Calculator and Chart | A-Z Guide
- LL-37 Antimicrobial Peptide Dosage Charts and Calculator
In clinical trials, Melanotan II was administered at doses starting from 0.01 mg/kg, escalating to 0.025-0.03 mg/kg subcutaneously. For tanning and sexual enhancement, typical dosing is 0.025 mg/kg daily (approximately 250-500 mcg for most adults), with protocols starting at 0.5 mg daily for the first week, then increasing to 1-2 mg daily.
Sources:
- Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study - PubMed
- Melanotan: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews
- https://alpha-rejuvenation.com/peptide-dosing/melanotan-ii-dosage/
- https://dermnetnz.org/topics/melanotan-ii
In the Phase 3 GLORY-1 trial, Mezdutide was administered at doses of 4 mg or 6 mg once weekly via subcutaneous injection, with treatment lasting 32-48 weeks and producing significant weight loss. Earlier phase trials explored higher doses up to 9-10 mg weekly with dose escalation protocols.
Sources:
- https://www.nejm.org/doi/full/10.1056/NEJMoa2411528
- https://pubmed.ncbi.nlm.nih.gov/40421736/
- https://www.nature.com/articles/s41467-023-44067-4
- https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.70040
Common dosing protocols for PEG-MGF (a stabilized form) involve approximately 200 mcg per day, often administered post-workout. In animal studies, MGF C-terminal peptide was administered at doses of 28.5-57 μg/kg body weight for bone healing applications.
Sources:
- https://muscleandbrawn.com/peptides/mgf-peptide/
- https://www.genemedics.com/pegylated-mechano-growth-factor
- https://swolverine.com/blogs/blog/peg-mgf-for-beginners-muscle-repair-dosing-and-stacking-guide
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3167400/
ModGRF 1-29 has a short half-life of approximately 30 minutes and is typically dosed at 100-200 mcg once or twice daily. Clinical studies have used CJC-1295 at doses of 30-60 mcg/kg administered subcutaneously, producing sustained increases in GH and IGF-1 levels.
Sources:
- https://www.peptidesciences.com/mod-grf-1-29-5mg-cjc-1295-no-dac
- CJC‑1295 For Beginners: How It Works, Benefits, Dosage, and Stacks
- https://www.limitlesslifenootropics.com/product/cjc-1295-no-dac-mod-grf-1-29/
- https://en.wikipedia.org/wiki/Modified_GRF_(1-29)
Research protocols typically use 5 mg of MOTS-c via subcutaneous injection every 5 days, or 10 mg up to 3 times weekly for more intensive protocols. Clinical dosing involves 0.5 mg (500 mcg) subcutaneously twice weekly for 4-6 weeks.
Sources:
- https://www.peptides.org/mots-c/
- https://peptidedosages.com/single-peptide-dosages/mots-c-10mg-vial-dosage-protocol/
- https://swolverine.com/blogs/blog/mots-c-for-beginners-benefits-dosage-stacking-and-side-effects
- https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-03885-2
Epithalon dosing protocols typically involve 10-day treatment courses administered no more than twice yearly, with clinical studies using intranasal delivery at 10-30 mg/day for 20-30 days or intramuscular injection at 5-10 mg/day for 10-20 days. N-Acetyl Epithalon Amidate is expected to have similar dosing to standard Epithalon but with enhanced stability and bioavailability.
Sources:
- https://www.peptidesciences.com/n-acetyl-epithalon-amidate-20mg
- https://jaycampbell.com/peptides/epitalon-the-life-extension-peptide/
- Epithalon Dosage Calculator and Chart | A-Z Guide
- Epitalon - Wikipedia
Based on Selank clinical data, typical dosing involves 250-750 mcg daily administered intranasally, with Russian clinical protocols using 0.15% solution (75 mcg per drop) three times daily for up to 14 days. For N-Acetyl Selank Amidate specifically, research protocols use 250-500 mcg per dose, 1-2 times daily via intranasal spray or subcutaneous injection.
Sources:
- https://www.peptides.org/n-acetyl-selank-amidate/
- https://www.peptides.org/n-acetyl-selank-amidate-nasal-spray/
- https://allaboutpeptides.com/selank-dosage-chart-and-calculator/
- https://www.labofrad.com/peptideinfo/n-acetyl-selank-amidate/
- https://en.wikipedia.org/wiki/Selank
Description: Nootropic peptide for cognitive enhancement and neuroprotection
Dosage: 300-600mcg daily (nasal or subcutaneous)
Sources:
- Peptides.org N-Acetyl Semax Guide
- N-Acetyl Semax Dosage Calculator
- PubMed Central - Semax Gene Expression Study
Description: Essential coenzyme for cellular energy production and anti-aging
Dosage: 250-750mg IV; 100-150mg sublingual daily
Sources:
- Fagron Academy NAD+ Dosing Review
- PubMed Central - Clinical Evidence for NAD
- Strive Pharmacy NAD+ Protocol
- PubMed Central - Oral NMN Administration
Description: Liver and gastrointestinal tract bioregulator for digestive health
Note: Ovagen is a liver and GI tract bioregulator, NOT for ovarian health as originally described.
Dosage: 1-2 capsules 1-2 times daily (oral); standard research dose for peptide
Sources:
41. Oxytocin
Description: Social bonding hormone with pain modulation and anxiolytic effects
Dosage: 10-40 IU nasal spray (typically 24-32 IU daily in clinical studies)
Sources:
- Nature - Advances in Intranasal Oxytocin Research
- PubMed Central - Oxytocin and Pain Inhibition
- Harbor Compounding Oxytocin Guide
- Empower Pharmacy Oxytocin Protocol
Description: Pancreatic bioregulator supporting pancreatic function and metabolic health
Dosage: 1-2 capsules 1-2 times daily; 20 units (2mg) daily for research
Sources:
42, PE-22-28
Description: Neurogenic peptide with antidepressant and cognitive enhancement properties
Dosage: 400-600mcg daily (intranasal); Research stage with limited human data
Sources:
43. PEG-MGF
Description: Pegylated mechano growth factor for muscle repair and recovery
Dosage: 200mcg 2-3x weekly post-training
Sources:
44. Pinealon
Description: Brain bioregulator peptide for neuroprotection and cognitive support
Dosage: 0.1-0.2mg twice daily; 4-6 drops (sublingual) 3-4x daily
Sources:
- Peptide Sciences Pinealon 20mg
- Jay Campbell Pinealon Guide
- PubMed Central - Pinealon Neuroprotection
- Peptide Bioregulator Pinealon Liquid
Description: Experimental anti-cancer peptide (FDA warning issued - not approved for use)
Dosage: Highly experimental - NO established safe human dosing
FDA WARNING: The FDA issued a warning against PNC-27 use in 2017 due to bacterial contamination and lack of approval.Sources:
- PubMed - PNC-27 Anti-Cancer Mechanism
- Annals of Clinical & Lab Science
- FDA Warning - PNC-27
- PubMed Central - PNC-27 Cancer Cell Study
Description: Prostate bioregulator for benign prostatic hyperplasia and prostate health
Dosage: 10-20mg daily (capsules or drops); 2 capsules daily for 30 days
Sources:
- Peptide Sciences Prostamax 20mg
- PubMed - Bioregulatory Peptides for BPH
- Exploring Peptides Dosing Schedule
Dosage Information:
- Subcutaneous: 100-500 mcg daily for 4-6 weeks
- Intranasal: 500 mcg-1mg daily, increased to 2-4mg for acute effects
- International Peptide Society: https://peptidesociety.org/_template-monographs-5/
- Core Peptides Research: https://www.corepeptides.com/p21-peptide-research-in-neurological-disorders-and-appetite/
- Peptide Sciences: https://www.peptidesciences.com/p21-p021-5mg
Dosage Information:
- Common dosage: 1.75 mg, roughly 45 minutes prior to anticipated sexual activity
- Advised to self-administer no more than once per day, for a maximum of 8 times per month
- Therapeutic dose ranges from 1.75 mg to 2 mg per administration
- Peptides.org Clinical Review: https://www.peptides.org/pt-141/
- Mayo Clinic (Bremelanotide): https://www.mayoclinic.org/drugs-su...e-subcutaneous-route/description/drg-20466805
- PMC Clinical Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/
- DrugBank Information: https://go.drugbank.com/drugs/DB11653
Dosage Information:
- Clinical trials studied doses of 1 mg, 4 mg, 8 mg, and 12 mg once weekly
- Dosage starts at 1 mg and is titrated every 4 weeks; maintenance dose can range from 4 mg, 8 mg, to 12 mg once weekly (maximum dose)
- Phase 2 trial showed mean weight reduction of 24.2% at 48 weeks with 12 mg dose
- New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
- PMC Scientific Analysis: https://pmc.ncbi.nlm.nih.gov/articles/PMC10844714/
- Eli Lilly Press Release: https://investor.lilly.com/news-rel...trutide-results-published-new-england-journal
- PubMed Clinical Trial: https://pubmed.ncbi.nlm.nih.gov/37366315/
Dosage Information:
- Clinical studies used 2700 μg/day intranasally
- Oral/Sublingual: 300 mcg to 1.5 mg per day
- Intranasal: 300 mcg – 1 mg per administration
- ScienceDirect Clinical Study: https://www.sciencedirect.com/science/article/abs/pii/S0924933812752811
- PMC Research (Diazepam interaction): https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/
- Wikipedia: https://en.wikipedia.org/wiki/Selank
- PMC GABAergic Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/
Dosage Information:
- Approved at doses up to 1 mg administered subcutaneously once weekly for type 2 diabetes
- For weight management: 2.4 mg once weekly subcutaneously
- High-dose studies evaluated up to 16 mg weekly
- NEJM (STEP Trial): https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- NEJM Cardiovascular Outcomes: https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
- Nature Medicine (STEP 5): https://www.nature.com/articles/s41591-022-02026-4
- Diabetes Care (High-dose): https://diabetesjournals.org/care/a...h-Dose-Semaglutide-Up-to-16-mg-in-People-With
Dosage Information:
- Intranasal: 16 mcg/kg body weight (single administration)
- 0.1% solution: 3 drops in each nostril 2 times daily for 10 days
- Injectable: 500-1000 mcg daily for up to 30 days
- Alzheimer's Discovery Foundation: https://www.alzdiscovery.org/upload.../Semax-Cognitive-Vitality-For-Researchers.pdf
- PMC Study (Ischemia): https://pmc.ncbi.nlm.nih.gov/articles/PMC3987924/
- AllAboutPeptides Dosage Guide: https://allaboutpeptides.com/semax-dosage-chart-and-calculator/
- Peptides.org Review: https://www.peptides.org/semax/
Dosage Information:
- 30 microg/kg bodyweight given at bedtime for children with growth hormone deficiency
- Adults: 200-300 mcg starting dose, typically 200-500 mcg per day via subcutaneous injection before bedtime
- Treatment cycles last 3 to 6 months, often using 5-day-on, 2-day-off protocol
- PMC Review Article: https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
- Mayo Clinic: https://www.mayoclinic.org/drugs-supplements/sermorelin-injection-route/description/drg-20065923
- PubMed Study: https://pubmed.ncbi.nlm.nih.gov/18031173/
- Wikipedia: https://en.wikipedia.org/wiki/Sermorelin
Dosage Information:
- Clinical trials used 40 mg subcutaneous daily doses for up to 260 weeks
- Intravenous: 0.05 mg/kg/hr for 1 hour in acute myocardial infarction trials
- Phase 2 trials tested 4 mg and 40 mg once daily subcutaneous doses
- Neurology Journal: https://www.neurology.org/doi/10.1212/WNL.0000000000005255
- PMC Kidney Disease Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/
- PNAS Protein Interaction Study: https://www.pnas.org/doi/10.1073/pnas.2002250117
- Alzheimer's Discovery Foundation: https://www.alzdiscovery.org/upload.../SS-31-Cognitive-Vitality-For-Researchers.pdf
Dosage Information:
- Phase 3 trials: doses uptitrated to 3.6 or 6.0 mg once weekly subcutaneously
- Phase 2 trial used 4.8 mg dose which resulted in mean 18.7% weight loss after 46 weeks
- Study doses ranged from 0.6 mg to 4.8 mg weekly
- PMC SYNCHRONIZE Trials Design: https://pmc.ncbi.nlm.nih.gov/articles/PMC11664303/
- PubMed Study: https://pubmed.ncbi.nlm.nih.gov/39495965/
- JACC Heart Failure: https://www.jacc.org/doi/10.1016/j.jchf.2024.09.004
- Diabetology & Metabolic Syndrome: https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-024-01501-x
Description: Thymosin beta-4 fragment promoting tissue repair and injury recovery
Dosage: Loading phase of 2-2.5 mg twice per week for 4-6 weeks (total 4-5 mg per week), followed by maintenance phase of 2 mg once every 1-2 weeks.
Sources:
- https://swolverine.com/blogs/blog/t...hould-you-take-for-recovery-and-injury-repair
- https://www.hubmeded.com/blog/tb-500-peptide-for-tissue-repair-and-flexibility
- https://www.peptides.org/tb-500-dosage-calculator/
Description: Growth hormone releasing hormone for visceral fat reduction
Dosage: 2 mg daily administered subcutaneously for visceral fat reduction in HIV patients. FDA-approved for reducing excess abdominal fat in HIV-infected patients with lipodystrophy.
Sources:
- https://www.innerbody.com/tesamorelin
- https://www.ncbi.nlm.nih.gov/books/NBK548730/
- https://www.mayoclinic.org/drugs-supplements/tesamorelin-subcutaneous-route/description/drg-20074632
Description: Bioregulator peptide for testosterone regulation and male vitality
Dosage: 20 mg per injection via subcutaneous administration, with treatment cycles spanning several weeks. One capsule each morning daily for thirty days, repeat every three to six months.
Sources:
- https://www.peptidesciences.com/testagen-20mg-bioregulator
- https://www.corepeptides.com/testagen-peptide-thyroid-research-and-studies-on-senescence/
- https://cosmicnootropic.com/products/testagen-bioregulator/
Description: Thymus bioregulator for immune system support and regeneration
Dosage: Typical dosage is 20 mg per injection via subcutaneous administration, with treatment cycles lasting several weeks. Daily injections ranging from 5-20 mg for 5-10 day courses.
Sources:
- https://www.peptidesciences.com/thymagen-bioregulator-20mg
- https://swolverine.com/blogs/blog/t...benefits-dosage-and-immune-support-strategies
- https://allaboutpeptides.com/thymalin-peptide-benefits/
Description: Thyroid stimulating hormone releasing factor for thyroid function testing
Dosage: Standard test dose of 400 μg administered intravenously for evaluating TSH secretion, as doses of 800 μg produced no greater response. Each vial contains 500 mcg protirelin for intravenous administration.
Sources:
- https://academic.oup.com/jcem/article-abstract/34/2/380/2685698
- https://www.drugs.com/pro/thyrotropin-releasing-hormone-trh.html
- https://www.yourhormones.info/hormones/thyrotropin-releasing-hormone/
Description: Dual GIP/GLP-1 receptor agonist for type 2 diabetes and obesity
Dosage: Starting dose of 2.5 mg weekly, may increase to 15 mg weekly for weight loss. At 5 mg per week dosing, showed 2.11% reduction in HbA1c, and at 15 mg per week showed 2.34% reduction.
Sources:
- https://medvidi.com/blog/tirzepatide-dosage
- https://www.ncbi.nlm.nih.gov/books/NBK585056/
- https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Description: GnRH agonist for prostate cancer treatment and reproductive regulation
Dosage: 3.75 mg IM every 4 weeks, 11.25 mg IM every 12 weeks, or 22.5 mg IM every 24 weeks for prostate cancer. For IVF treatment, minimal daily dose of 15 microgram daily has been determined.
Sources:
- https://www.drugs.com/dosage/triptorelin.html
- https://en.wikipedia.org/wiki/Triptorelin
- https://medlineplus.gov/druginfo/meds/a611047.html
Description: Vascular bioregulator supporting blood vessel health and circulation
Dosage: Take 1-2 capsules one to two times daily, 30 minutes before meals for 1 month, repeat every 4-6 months. Daily dose of 2-5 ml sublingual contains 0.1 mg of peptide complex AC-2 for 10 days.
Sources:
- https://www.antiaging-systems.com/products/blood-vessel-bioregulator-vesugen/
- https://peptide-bioregulator.com/product/vesugen/
- https://www.peptidesciences.com/vesugen-20mg-bioregulator
Description: Bladder and urinary tract bioregulator peptide
Dosage: In research settings, typically dosed at 10-20 mg per week administered subcutaneously in 2-3 injections per week for 2 to 6 weeks. One capsule twice daily (morning and evening) during meals for at least 20 days, repeat after 4-6 months.
Sources:
- https://www.dragonpharma.net/peptide-hubs-3750/vesilute-20-mg-85154
- https://www.peptidesciences.com/vesilute-bioregulator-20mg
- https://cosmicnootropic.com/products/vesilut-bioregulator/
Description: Immune system bioregulator affecting thymus function and cellular immunity
Dosage: For research, typically administered subcutaneously at 5 mg per day over a 12-day cycle, repeated every four to six months. Clinical dosing is individualized but commonly follows a 10-day cycle every 3-6 months.
Sources:
- https://world-of-peptides.com/vilon...s-uses-benefits-dosage-and-in-depth-insights/
- https://www.peptidesciences.com/vilon-20mg
- https://muscleandbrawn.com/peptides/vilon-essential-insights-on-benefits/
Description: Neuropeptide with vasodilatory and anti-inflammatory effects
Dosage: Graded doses of 0.6, 1.3, and 3.3 pmol/kg/min were intravenously infused over 30 minute periods in clinical studies. For nasal spray administration, 1 spray (50 mcg) four times daily alternating nostrils for the first month, may increase to 2 sprays (100 mcg) four times daily for the second month.
Sources:
- https://pmc.ncbi.nlm.nih.gov/articles/PMC1412244/
- https://www.strivepharmacy.com/medications/vasoactive-intestinal-peptide-vip-nasal-spray
- https://en.wikipedia.org/wiki/Vasoactive_intestinal_peptide
1. Legal and Safety Risks:
• Non-FDA-approved peptides have not undergone rigorous safety and efficacy testing required by regulatory authorities
• Manufacturing standards, purity, and dosing accuracy may vary significantly between sources
• Long-term effects and potential adverse reactions are often unknown or poorly documented
• Use of non-approved compounds may carry legal implications depending on your jurisdiction
2. Source Verification:
• Never purchase peptides from unverified or questionable sources
• Contamination, mislabeling, incorrect concentrations, and counterfeit products are serious concerns in the unregulated peptide market
• Even compounds labeled as “research use only” or “not for human consumption” may be marketed for human use inappropriately
• Third-party testing and certificates of analysis (COAs) should be verified independently when possible
3. Medical Supervision:
• Always consult with a qualified healthcare provider before using any peptide
• Self-administration of experimental compounds without medical supervision can be dangerous
• Pre-existing health conditions, medications, and individual factors can significantly affect safety and outcomes
• Regular monitoring and lab work may be necessary to prevent adverse effects
Last edited:
